Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mesa Laboratories Inc.

    NASDAQ: MLAB · Real-Time Price · USD
    97.26
    -2.63 (-2.63%)
    At close: Jun 13, 2025, 3:59 PM
    97.10
    -0.16%
    After-hours: Jun 13, 2025, 04:04 PM EDT

    Mesa Laboratories Statistics

    Share Statistics

    Mesa Laboratories has 5.46M shares outstanding. The number of shares has increased by 0.73% in one year.

    Shares Outstanding

    n/a
    		 5.46M

    Shares Change (YoY)

    n/a
    		 0.73%

    Shares Change (QoQ)

    n/a
    		 0.04%

    Owned by Institutions (%)

    n/a
    		 94.01%

    Shares Floating

    n/a
    		 5.32M

    Failed to Deliver (FTD) Shares

    n/a
    		 164

    FTD / Avg. Volume

    n/a
    		 0.26%

    Short Selling Information

    The latest short interest is 183.16K, so 3.36% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 183.16K

    Short % of Shares Out

    n/a
    		 3.36%

    Short % of Float

    n/a
    		 4.88%

    Short Ratio (days to cover)

    n/a
    		 4.28

    Valuation Ratios

    The PE ratio is -2.37 and the forward PE ratio is 10.99. Mesa Laboratories's PEG ratio is 0.

    PE Ratio

    n/a
    		 -2.37

    Forward PE

    n/a
    		 10.99

    PS Ratio

    n/a
    		 2.79

    Forward PS

    n/a
    		 2.1

    PB Ratio

    n/a
    		 4.15

    P/FCF Ratio

    n/a
    		 14.51

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Mesa Laboratories.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.47, with a Debt / Equity ratio of 1.59.

    Current Ratio

    n/a
    		 2.47

    Quick Ratio

    n/a
    		 1.73

    Debt / Equity

    n/a
    		 1.59

    Debt / EBITDA

    n/a
    		 -0.97

    Debt / FCF

    n/a
    		 5.56

    Interest Coverage

    n/a
    		 -47.76

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $293,732.34

    Profits Per Employee

    n/a
    		 $-345,442.93

    Employee Count

    n/a
    		 736

    Asset Turnover

    n/a
    		 0.48

    Inventory Turnover

    n/a
    		 2.54

    Taxes

    Income Tax

    n/a
    		 -21.4M

    Effective Tax Rate

    n/a
    		 7.76%

    Stock Price Statistics

    The stock price has increased by 6.18% in the last 52 weeks. The beta is 0.89, so Mesa Laboratories's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.89

    52-Week Price Change

    n/a
    		 6.18%

    50-Day Moving Average

    n/a
    		 112.1

    200-Day Moving Average

    n/a
    		 124.53

    Relative Strength Index (RSI)

    n/a
    		 34.42

    Average Volume (20 Days)

    n/a
    		 63,746

    Income Statement

    In the last 12 months, Mesa Laboratories had revenue of 216.19M and earned -254.25M in profits. Earnings per share was -47.2.

    Revenue

    n/a
    		 216.19M

    Gross Profit

    n/a
    		 133.25M

    Operating Income

    n/a
    		 -272.07M

    Net Income

    n/a
    		 -254.25M

    EBITDA

    n/a
    		 -238.38M

    EBIT

    n/a
    		 -269.95M

    Earnings Per Share (EPS)

    n/a
    		 -47.2
    Full Income Statement

    Balance Sheet

    The company has 28.21M in cash and 231.3M in debt, giving a net cash position of -203.08M.

    Cash & Cash Equivalents

    n/a
    		 28.21M

    Total Debt

    n/a
    		 231.3M

    Net Cash

    n/a
    		 -203.08M

    Retained Earnings

    n/a
    		 -183.49M

    Total Assets

    n/a
    		 437.15M

    Working Capital

    n/a
    		 -45.03M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 44.13M and capital expenditures -2.57M, giving a free cash flow of 41.57M.

    Operating Cash Flow

    n/a
    		 44.13M

    Capital Expenditures

    n/a
    		 -2.57M

    Free Cash Flow

    n/a
    		 41.57M

    FCF Per Share

    n/a
    		 7.72
    Full Cash Flow Statement

    Margins

    Gross margin is 61.64%, with operating and profit margins of -125.85% and -117.6%.

    Gross Margin

    n/a
    		 61.64%

    Operating Margin

    n/a
    		 -125.85%

    Pretax Margin

    n/a
    		 -127.5%

    Profit Margin

    n/a
    		 -117.6%

    EBITDA Margin

    n/a
    		 -110.26%

    EBIT Margin

    n/a
    		 -125.85%

    FCF Margin

    n/a
    		 19.23%

    Dividends & Yields

    MLAB pays an annual dividend of $0.8, which amounts to a dividend yield of 0.64%.

    Dividend Per Share

    n/a
    		 $0.80

    Dividend Yield

    n/a
    		 0.64%

    Dividend Growth (YoY)

    n/a
    		 0%

    Payout Ratio

    n/a
    		 -222.22%

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MLAB is $130, which is 33.7% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $130

    Price Target Difference

    n/a
    		 33.7%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.92

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist